Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma

Journal of Rheumatology

Volumn 32, Issue 10, 2005, Pages 1884-1887

  Cuttner, Janet ^a,b   Spiera, Harry ^a,b   Troy, Kevin ^a,b,c   Wallenstein, Sylvan ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Medicine ^*  (United States)

^c HQ MEDCOM   (United States)

Author keywords

Autoimmune disease; Epidemiology; Non Hodgkin's lymphoma

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CYCLOSPORIN; GOLD; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; METHOTREXATE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FISHER EXACT TEST; HEMATOLOGIC DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 26444476451     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, editors. SEER Cancer Statistics Review, 1973-1991: Tables and Graphs, National Cancer Institute. Bethesda, MD: NIH Publication No. 94-2789.
2. Goss PE. Non-Hodgkin's lymphomas in elderly patients. Leuk Lymphoma 1993;10:147-56.
3. Kinlen LJ, Sheil AGR, Peto J, Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. BMJ 1979;2:1461-6.
4. Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Nat Cancer Inst 1993;85:307-11.
5. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
6. Kinlen LJ. Malignancy in autoimmune diseases. J Autoimmun 1992;5:363-71.
7. 6A. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989;7:1630-6.
8. Erratum in: J Clin Oncol 1990;8:1602.
9. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
10. Collins J, Gough S. Autoimmunity in thyroid disease. Eur J Nucl Med 2002;29 Suppl 2:5417-24.
11. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119:234-42.
12. Catassi C, Fabiani E, Corrao G, et al. Risk of non-Hodgkin's lymphoma in celiac disease. JAMA 2002;287:1413-9.
13. Whitacre CC. Sex differences in autoimmune disease. Nature Immunol 2001;2:777-80.
14. Leandro J, Isenberg DA. Rheumatic diseases and malignancy - is there an association? Scand J Rheumatol 2001;30:185-8.
15. Pariente D, Anaya JM, Combe B, et al. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome. Eur J Med 1992;1:337-42.
16. Kruize AA, Hene RJ, van der Heide A, et al. Long term follow up of patients with Sjögren's syndrome. Arthritis Rheum 1996;39:297-303.
17. Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol 1988;19:1315-26.
18. Cuttner J, Wallenstein S, Troy KM. Non-Hodgkin's lymphoma in patients 70 years of age or older: factors associated with survival. Leukemia Res 2002;26:447-50.
19. Jameson JL, Weetman AP. Disorders of the thyroid gland. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine. 15th ed. New York: McGraw-Hill Medical Publishing Division; 2001:2060-84.
20. Moutsopoulos HM. Sjögren's syndrome. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine. 15th ed. New York: McGraw-Hill Medical Publishing Division; 2001:1947-9.